30 Mar 2021
In line FY20 prelims – significant contract award
Having upgraded several times in the year, EKF’s FY20 results are as expected and show a step change in the performance of the business. Whilst this has been catalysed by the pandemic and sales of sample collection devices, the core business has held up relatively well and is showing an encouraging return to growth in Q1. The main new news this morning is a significant multi-year, multi-million dollar contract expansion for sample collection devices with a multinational private sector partner. W ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
In line FY20 prelims – significant contract award
EKF Diagnostics Holdings plc (EKF:LON) | 27.2 0.1 0.7% | Mkt Cap: 123.4m
- Published:
30 Mar 2021 -
Author:
Chris Glasper -
Pages:
3
Having upgraded several times in the year, EKF’s FY20 results are as expected and show a step change in the performance of the business. Whilst this has been catalysed by the pandemic and sales of sample collection devices, the core business has held up relatively well and is showing an encouraging return to growth in Q1. The main new news this morning is a significant multi-year, multi-million dollar contract expansion for sample collection devices with a multinational private sector partner. W ....